US Stock MarketDetailed Quotes

Heron Therapeutics (HRTX)

Watchlist
  • 1.450
  • -0.010-0.68%
Close Jan 22 16:00 ET
  • 1.400
  • -0.050-3.45%
Pre 06:25 ET
265.88MMarket Cap-16.11P/E (TTM)

Heron Therapeutics (HRTX) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-60.52%1.33M
-136.06%-10.87M
6.79%-8.87M
61.68%-22.53M
-579.84%-11.78M
136.73%3.37M
83.05%-4.6M
61.78%-9.52M
59.98%-58.79M
106.54%2.46M
Net income from continuing operations
-260.87%-17.5M
74.22%-2.38M
183.39%2.64M
87.72%-13.58M
134.16%3.66M
80.61%-4.85M
78.04%-9.24M
90.36%-3.16M
39.26%-110.56M
46.03%-10.72M
Operating gains losses
--11.24M
--129K
---34K
598.88%4.38M
----
----
----
----
121.55%627K
189.00%604K
Depreciation and amortization
5.85%615K
-4.68%611K
-20.03%551K
-14.04%2.49M
-18.74%581K
-20.08%581K
-13.26%641K
-4.04%689K
0.35%2.9M
-9.61%715K
Other non cash items
-48.01%196K
43.06%206K
50.71%211K
183.48%961K
84.05%300K
416.44%377K
176.92%144K
174.51%140K
67.82%339K
226.00%163K
Change In working capital
-14.43%3.64M
-250.41%-11.99M
-43.31%-14.46M
-264.40%-27.6M
-318.32%-18.34M
-50.13%4.25M
-986.53%-3.42M
-1,811.36%-10.09M
259.81%16.79M
129.45%8.4M
-Change in receivables
-116.73%-1.12M
85.75%-1.2M
102.80%145K
-131.75%-18.74M
-423.73%-11.84M
-48.29%6.67M
66.78%-8.39M
-962.73%-5.19M
51.13%-8.09M
137.10%3.66M
-Change in inventory
195.27%2.94M
-4,000.51%-16.03M
-939.12%-3.77M
-188.66%-11.05M
-6,900.00%-7.21M
-217.97%-3.09M
-105.26%-391K
-114.44%-363K
301.31%12.46M
95.59%-103K
-Change in prepaid assets
-36.81%-5.25M
3,118.69%9.3M
-3,775.68%-8.6M
-164.35%-9.93M
-226.06%-6.16M
-2,330.23%-3.84M
-96.95%289K
-124.50%-222K
1,427.33%15.43M
203.58%4.89M
-Change in payables and accrued expense
56.73%7.06M
-180.24%-4.07M
48.36%-2.23M
502.46%12.12M
18,171.05%6.87M
162.98%4.51M
-41.98%5.07M
4.99%-4.32M
-126.82%-3.01M
99.67%-38K
Cash from discontinued investing activities
Operating cash flow
-60.52%1.33M
-136.06%-10.87M
6.79%-8.87M
61.68%-22.53M
-579.84%-11.78M
136.73%3.37M
83.05%-4.6M
61.78%-9.52M
59.98%-58.79M
106.54%2.46M
Investing cash flow
Cash flow from continuing investing activities
198.69%11.86M
258.11%7.33M
77.86%2.27M
4.00%18.71M
229.22%11.42M
117.10%3.97M
-84.51%2.05M
-96.53%1.28M
641.37%18M
-537.21%-8.84M
Net PPE purchase and sale
106.73%29K
69.07%-197K
---67K
-9.60%-1.68M
-157.81%-611K
45.65%-431K
-129.14%-637K
--0
4.13%-1.53M
42.34%-237K
Net investment purchase and sale
168.78%11.83M
180.48%7.53M
83.10%2.34M
4.43%20.39M
239.89%12.03M
119.62%4.4M
-80.11%2.69M
-96.55%1.28M
1,231.34%19.53M
-453.58%-8.6M
Cash from discontinued investing activities
Investing cash flow
198.69%11.86M
258.11%7.33M
77.86%2.27M
4.00%18.71M
229.22%11.42M
117.10%3.97M
-84.51%2.05M
-96.53%1.28M
641.37%18M
-537.21%-8.84M
Financing cash flow
Cash flow from continuing financing activities
95,350.00%13.36M
-98.26%940K
112.56%423K
-99.97%14K
54.23%492K
105.29%11K
-27.91%54.11M
-54.67%199K
Net issuance payments of debt
----
----
----
--0
--0
----
----
----
--24.35M
--0
Net common stock issuance
----
----
----
--0
--0
----
----
----
-60.40%29.76M
--0
Proceeds from stock option exercised by employees
-464.29%-51K
----
----
46,900.00%940K
112.56%423K
104.55%14K
54.23%492K
105.29%11K
102.33%2K
-56.46%199K
Cash from discontinued financing activities
Financing cash flow
95,350.00%13.36M
58.74%781K
481.82%64K
-98.26%940K
112.56%423K
-99.97%14K
54.23%492K
105.29%11K
-27.91%54.11M
-54.67%199K
Net cash flow
Beginning cash position
-10.17%16.52M
-5.78%19.27M
-10.03%25.8M
86.65%28.68M
-26.16%25.74M
36.58%18.39M
-24.51%20.45M
86.65%28.68M
-83.03%15.36M
-30.89%34.86M
Current changes in cash
261.01%26.55M
-33.38%-2.75M
20.59%-6.53M
-121.60%-2.88M
100.99%61K
-65.63%7.36M
84.85%-2.06M
-170.16%-8.23M
117.71%13.31M
82.37%-6.18M
End cash Position
67.31%43.07M
-10.17%16.52M
-5.78%19.27M
-10.03%25.8M
-10.03%25.8M
-26.16%25.74M
36.58%18.39M
-24.51%20.45M
86.65%28.68M
86.65%28.68M
Free cash flow
-54.73%1.33M
-111.33%-11.08M
5.64%-8.98M
59.83%-24.24M
-663.17%-12.42M
129.48%2.94M
80.90%-5.24M
62.12%-9.52M
59.44%-60.33M
105.81%2.21M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -60.52%1.33M-136.06%-10.87M6.79%-8.87M61.68%-22.53M-579.84%-11.78M136.73%3.37M83.05%-4.6M61.78%-9.52M59.98%-58.79M106.54%2.46M
Net income from continuing operations -260.87%-17.5M74.22%-2.38M183.39%2.64M87.72%-13.58M134.16%3.66M80.61%-4.85M78.04%-9.24M90.36%-3.16M39.26%-110.56M46.03%-10.72M
Operating gains losses --11.24M--129K---34K598.88%4.38M----------------121.55%627K189.00%604K
Depreciation and amortization 5.85%615K-4.68%611K-20.03%551K-14.04%2.49M-18.74%581K-20.08%581K-13.26%641K-4.04%689K0.35%2.9M-9.61%715K
Other non cash items -48.01%196K43.06%206K50.71%211K183.48%961K84.05%300K416.44%377K176.92%144K174.51%140K67.82%339K226.00%163K
Change In working capital -14.43%3.64M-250.41%-11.99M-43.31%-14.46M-264.40%-27.6M-318.32%-18.34M-50.13%4.25M-986.53%-3.42M-1,811.36%-10.09M259.81%16.79M129.45%8.4M
-Change in receivables -116.73%-1.12M85.75%-1.2M102.80%145K-131.75%-18.74M-423.73%-11.84M-48.29%6.67M66.78%-8.39M-962.73%-5.19M51.13%-8.09M137.10%3.66M
-Change in inventory 195.27%2.94M-4,000.51%-16.03M-939.12%-3.77M-188.66%-11.05M-6,900.00%-7.21M-217.97%-3.09M-105.26%-391K-114.44%-363K301.31%12.46M95.59%-103K
-Change in prepaid assets -36.81%-5.25M3,118.69%9.3M-3,775.68%-8.6M-164.35%-9.93M-226.06%-6.16M-2,330.23%-3.84M-96.95%289K-124.50%-222K1,427.33%15.43M203.58%4.89M
-Change in payables and accrued expense 56.73%7.06M-180.24%-4.07M48.36%-2.23M502.46%12.12M18,171.05%6.87M162.98%4.51M-41.98%5.07M4.99%-4.32M-126.82%-3.01M99.67%-38K
Cash from discontinued investing activities
Operating cash flow -60.52%1.33M-136.06%-10.87M6.79%-8.87M61.68%-22.53M-579.84%-11.78M136.73%3.37M83.05%-4.6M61.78%-9.52M59.98%-58.79M106.54%2.46M
Investing cash flow
Cash flow from continuing investing activities 198.69%11.86M258.11%7.33M77.86%2.27M4.00%18.71M229.22%11.42M117.10%3.97M-84.51%2.05M-96.53%1.28M641.37%18M-537.21%-8.84M
Net PPE purchase and sale 106.73%29K69.07%-197K---67K-9.60%-1.68M-157.81%-611K45.65%-431K-129.14%-637K--04.13%-1.53M42.34%-237K
Net investment purchase and sale 168.78%11.83M180.48%7.53M83.10%2.34M4.43%20.39M239.89%12.03M119.62%4.4M-80.11%2.69M-96.55%1.28M1,231.34%19.53M-453.58%-8.6M
Cash from discontinued investing activities
Investing cash flow 198.69%11.86M258.11%7.33M77.86%2.27M4.00%18.71M229.22%11.42M117.10%3.97M-84.51%2.05M-96.53%1.28M641.37%18M-537.21%-8.84M
Financing cash flow
Cash flow from continuing financing activities 95,350.00%13.36M-98.26%940K112.56%423K-99.97%14K54.23%492K105.29%11K-27.91%54.11M-54.67%199K
Net issuance payments of debt --------------0--0--------------24.35M--0
Net common stock issuance --------------0--0-------------60.40%29.76M--0
Proceeds from stock option exercised by employees -464.29%-51K--------46,900.00%940K112.56%423K104.55%14K54.23%492K105.29%11K102.33%2K-56.46%199K
Cash from discontinued financing activities
Financing cash flow 95,350.00%13.36M58.74%781K481.82%64K-98.26%940K112.56%423K-99.97%14K54.23%492K105.29%11K-27.91%54.11M-54.67%199K
Net cash flow
Beginning cash position -10.17%16.52M-5.78%19.27M-10.03%25.8M86.65%28.68M-26.16%25.74M36.58%18.39M-24.51%20.45M86.65%28.68M-83.03%15.36M-30.89%34.86M
Current changes in cash 261.01%26.55M-33.38%-2.75M20.59%-6.53M-121.60%-2.88M100.99%61K-65.63%7.36M84.85%-2.06M-170.16%-8.23M117.71%13.31M82.37%-6.18M
End cash Position 67.31%43.07M-10.17%16.52M-5.78%19.27M-10.03%25.8M-10.03%25.8M-26.16%25.74M36.58%18.39M-24.51%20.45M86.65%28.68M86.65%28.68M
Free cash flow -54.73%1.33M-111.33%-11.08M5.64%-8.98M59.83%-24.24M-663.17%-12.42M129.48%2.94M80.90%-5.24M62.12%-9.52M59.44%-60.33M105.81%2.21M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More